Does ENZALUTAMIDE Cause Product odour abnormal? 44 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Product odour abnormal have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
44
Reports of Product odour abnormal with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
2
Deaths
2
Hospitalizations
How Dangerous Is Product odour abnormal From ENZALUTAMIDE?
Of the 44 reports, 2 (4.5%) resulted in death, 2 (4.5%) required hospitalization.
Is Product odour abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Product odour abnormal?
ICOSAPENT ETHYL (911)
BUPROPION (491)
FLUTICASONE (482)
POLYETHYLENE GLYCOL 3350 (381)
METFORMIN (323)
OMEGA-3-ACID ETHYL ESTERS (194)
IBUPROFEN (184)
LEVOTHYROXINE (155)
TESTOSTERONE (145)
PROGESTERONE (134)
Which ENZALUTAMIDE Alternatives Have Lower Product odour abnormal Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE